BANK OF AMERICA CORP /DE/ - CABALETTA BIO INC ownership

CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 97 filers reported holding CABALETTA BIO INC in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CABALETTA BIO INC
ValueSharesWeighting
Q3 2023$2,148,851
+552.8%
141,186
+453.7%
0.00%
Q2 2023$329,179
+349.7%
25,498
+188.1%
0.00%
Q1 2023$73,197
+546.0%
8,851
+622.5%
0.00%
Q4 2022$11,331
+88.8%
1,225
-86.7%
0.00%
Q3 2022$6,000
-62.5%
9,194
-39.7%
0.00%
Q2 2022$16,000
-75.8%
15,247
-52.9%
0.00%
Q1 2022$66,000
+144.4%
32,379
+355.3%
0.00%
Q4 2021$27,000
-84.7%
7,111
-51.0%
0.00%
Q3 2021$176,000
+1.1%
14,507
-28.2%
0.00%
Q2 2021$174,000
+56.8%
20,205
+102.5%
0.00%
Q1 2021$111,000
+177.5%
9,978
+214.8%
0.00%
Q4 2020$40,000
-9.1%
3,170
-22.0%
0.00%
Q3 2020$44,000
-41.3%
4,065
-39.0%
0.00%
Q2 2020$75,000
+200.0%
6,659
+99.3%
0.00%
Q1 2020$25,000
+56.2%
3,342
+194.4%
0.00%
Q4 2019$16,0001,1350.00%
Other shareholders
CABALETTA BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 2,106,000$32,053,32021.20%
COMMODORE CAPITAL LP 2,525,753$38,441,9614.49%
Bain Capital Life Sciences Investors, LLC 2,000,000$30,440,0003.40%
VR Adviser, LLC 1,973,253$30,032,9113.16%
Cormorant Asset Management, LP 2,879,424$43,824,8332.56%
Velan Capital Investment Management LP 150,000$2,283,0001.84%
Redmile Group, LLC 1,774,252$27,004,1151.28%
TCG Crossover Management, LLC 486,795$7,409,0201.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,340,118$35,616,5960.78%
Integral Health Asset Management, LLC 330,000$5,022,6000.70%
View complete list of CABALETTA BIO INC shareholders